Featured Document
May 13, 2021

HHS Communications Regarding FDA Decision on Convalescent Plasma

Records from the U.S. Department of Health and Human Services in response to American Oversight's request for FDA communications regarding Covid-19 treatments. These records include communication concerning the FDA's decision to on convalescent plasma from August 2020.

Statusactive

Records from the U.S. Department of Health and Human Services in response to American Oversight’s request for FDA communications regarding Covid-19 treatments. These records include communication concerning the FDA’s decision to on convalescent plasma from August 2020.

Stay Informed

Get the latest from American Oversight in your inbox.

This field is for validation purposes and should be left unchanged.
Name